Option Care Health, Inc. Stock

Equities

OPCH

US68404L2016

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
30.12 USD -0.53% Intraday chart for Option Care Health, Inc. +1.04% -10.60%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 4.75B Sales 2025 * 5.17B Capitalization 5.24B
Net income 2024 * 204M Net income 2025 * 234M EV / Sales 2024 * 1.22 x
Net Debt 2024 * 559M Net Debt 2025 * 348M EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
25.9 x
P/E ratio 2025 *
22.6 x
Employees 6,806
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.53%
1 week+1.04%
Current month+0.77%
1 month-4.02%
3 months-7.97%
6 months+5.50%
Current year-10.60%
More quotes
1 week
29.73
Extreme 29.73
30.66
1 month
28.75
Extreme 28.75
31.79
Current year
28.75
Extreme 28.75
34.63
1 year
26.17
Extreme 26.17
35.74
3 years
16.18
Extreme 16.175
35.87
5 years
5.74
Extreme 5.74
35.87
10 years
5.74
Extreme 5.74
35.87
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 19-08-05
Director of Finance/CFO 53 14-12-31
Compliance Officer - -
Members of the board TitleAgeSince
Chairman 69 19-08-06
Director/Board Member 62 15-04-30
Director/Board Member 74 19-08-06
More insiders
Date Price Change Volume
24-05-10 30.12 -0.53% 1,021,221
24-05-09 30.28 +0.20% 1,321,648
24-05-08 30.22 -0.33% 1,748,362
24-05-07 30.32 +1.00% 1,361,266
24-05-06 30.02 +0.70% 1,083,113

Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT

More quotes
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
30.12 USD
Average target price
39.57 USD
Spread / Average Target
+31.38%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW